Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial

ConditionGestational Diabetes Mellitus in Pregnancy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorUniversity of California, Los Angeles

About this trial

This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes.

Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.

Eligibility criteria

Qualifiers

Prenatal care at UCLA Health

Planning to deliver at UCLA Ronald Reagan or UCLA Santa Monica

Confirmed gestational diabetes diagnosis based on 2-step approach

Maternal age >= 18 years

Disqualifiers

Pre-gestational diabetes (T1DM or T2DM)

Multifetal gestation

Intra-amniotic infection by clinical criteria

Postpartum hemorrhage

Trial design

Treatments tested in this trial

Continuous Glucose Monistor

Treatment groups

50 Participants

are divided into 1 treatment group

Sponsors and collaborators

University of California, Los Angeles

Lead sponsor

Source ClinicalTrials.gov